Investigating of harmane, harmine, and norharman as inhibitors of MDR1 and MRP1 to overcome chemotherapy resistance in cancer cells. [PDF]
Abdi N +5 more
europepmc +1 more source
Network pharmacology analysis and experimental validation of the gastric cancer-related targets of harmine. [PDF]
Hu Y +8 more
europepmc +1 more source
Emerging role of DYRK1A as a target in cardiovascular diseasesĀ (Review). [PDF]
Yu L, Cheng Q, Wu J.
europepmc +1 more source
Editorial: Plant bioactive compounds as modulators of oncogenic signalling pathways in cervical cancer. [PDF]
Pandey P, Hussain A, Khan F.
europepmc +1 more source
Mixed-methods analysis on psychedelic-augmented meditation experiences from a randomized controlled mindfulness retreat. [PDF]
Schlomberg JTT +5 more
europepmc +1 more source
Correction: Harmine derivative B-9-3 inhibits non-small cell lung cancer via the VEGFA/PI3K/AKT pathway. [PDF]
Wu Y, Wang B, Mao X, Chen W, Aisa HA.
europepmc +1 more source
Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of <i>N,N</i>-dimethyltryptamine and harmine in a meditation retreat. [PDF]
Egger K +5 more
europepmc +1 more source
Antibacterial and antiviral potential of harmalacidine hydrochloride, a β-carboline alkaloid, against respiratory tract pathogens: Staphylococcus aureus and H1N1 influenza virus. [PDF]
Alossaimi MA +3 more
europepmc +1 more source
Genetic recording of pancreatic beta cell proliferation. [PDF]
Zhao H +9 more
europepmc +1 more source
Harmine Derivatives as Anticancer Agents Endowed With Potent and Selective Antileukemia Activity: Synthesis, Biological Evaluation, Proapoptotic and Genotoxic Activity. [PDF]
Timbilla AA +17 more
europepmc +1 more source

